About Bio-Rad Laboratories, Inc
Bio-Rad provides the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results.
2BBBullish & Bearish
Bio-Rad Laboratories, Inc (BIO) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 37 out of 100.
Bio-Rad provides the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results.
Bio-Rad Laboratories, Inc’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 31 | Low |
| Momentum | 39 | Weakening |
| Financial strength | 59 | Normal |
| Company Presence | 71 | Strong |
| Risk | 6 | Very Low (provisional) |
| CEO | Norman David Schwartz |
| Headquarters | Hercules, California, United States |
| Founded | 1952 |
| Employees | 7.45K |
| P/E ratio | 43.94 |
| 52-week range | $236.73 – $396.23 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-04-28 | — | 3.0199 | — | $618.17M |
| 2027-02-10 | — | 3.0502 | — | $702.35M |
| 2026-11-04 | — | 2.2473 | — | $656.45M |
| 2026-08-04 | — | 1.7652 | — | $630.23M |